Literature DB >> 18559545

Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda.

Mahboobeh Safaeian1, Mohammad Kiddugavu, Patti E Gravitt, Stephen J Gange, Joseph Ssekasanvu, Dan Murokora, Marc Sklar, David Serwadda, Maria J Wawer, Keerti V Shah, Ron Gray.   

Abstract

BACKGROUND: We used self-administered vaginal swabs to assess the incidence and clearance of carcinogenic human papillomavirus (HPV) infections in rural Rakai, Uganda.
METHODS: Women provided self-administered vaginal swab at annual home-based visits. Type-specific carcinogenic HPV incidence and clearance and risk factors were assessed.
RESULTS: Carcinogenic HPV incidence was 17.3 per 100 person-years among HIV-positive women compared with 7.0 per 100 person-years among HIV-negative women (P < 0.001). HPV-51 had the highest incidence followed by HPV-16 (1.8 per 100 and 1.5 per 100 person-years, respectively). In multivariate model, HIV-positive women were twice as likely to have incident infection compared with HIV-negative women. Younger women were at higher risk for incident infection, as were women with higher lifetime and recent sexual partners, and high perception of AIDS. Married women were less likely to have incident infection. Approximately half of all carcinogenic HPV infections cleared over the study follow-up of 3 years. HPV-31, HPV-35, and HPV-16 had the lowest clearance (16.7%, 27.9%, and 38.3%, respectively). In multivariate model, HIV-positive, women over 30 years with higher HPV viral, burden and more lifetime sex partners were less likely to clear infections.
CONCLUSIONS: Self-collected vaginal swabs provide accurate HPV exposure assessment for studying HPV exposure and epidemiology and can be an important tool for research in populations unwilling to undergo pelvic exam.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559545      PMCID: PMC3158656          DOI: 10.1158/1055-9965.EPI-07-2678

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  38 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  An overview of cancer survival in developing countries.

Authors:  R Sankaranarayanan; R J Black; R Swaminathan; D M Parkin
Journal:  IARC Sci Publ       Date:  1998

Review 3.  Screening patterns for cervical cancer: how best to reach the unscreened population.

Authors:  C L Brown
Journal:  J Natl Cancer Inst Monogr       Date:  1996

4.  Comparison of type-specific human papillomavirus data from self and clinician directed sampling.

Authors:  Susie Baldwin; Carlos Santos; Elena Mendez Brown; Thomas Nuño; Anna Giuliano; John Davis; Francisco Garcia
Journal:  Gynecol Oncol       Date:  2005-05       Impact factor: 5.482

5.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Human papillomavirus infection in women infected with the human immunodeficiency virus.

Authors:  X W Sun; L Kuhn; T V Ellerbrock; M A Chiasson; T J Bush; T C Wright
Journal:  N Engl J Med       Date:  1997-11-06       Impact factor: 91.245

7.  Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results.

Authors:  Nubia Muñoz; Fabián Méndez; Héctor Posso; Mónica Molano; Adrian J C van den Brule; Margarita Ronderos; Chris Meijer; Alvaro Muñoz
Journal:  J Infect Dis       Date:  2004-11-22       Impact factor: 5.226

8.  Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.

Authors:  E L Franco; L L Villa; J P Sobrinho; J M Prado; M C Rousseau; M Désy; T E Rohan
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

9.  The natural history of type-specific human papillomavirus infections in female university students.

Authors:  Harriet Richardson; Gail Kelsall; Pierre Tellier; Hélène Voyer; Michal Abrahamowicz; Alex Ferenczy; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-06       Impact factor: 4.254

10.  Comparison of adolescent and young adult self-collected and clinician-collected samples for human papillomavirus.

Authors:  Jessica A Kahn; Gail B Slap; Bin Huang; Susan L Rosenthal; Abbigail M Wanchick; Linda M Kollar; Paula A Hillard; David Witte; Pam Groen; David I Bernstein
Journal:  Obstet Gynecol       Date:  2004-05       Impact factor: 7.661

View more
  30 in total

1.  Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.

Authors:  Arati Mane; Vikrant V Sahasrabuddhe; Amit Nirmalkar; Arun R Risbud; Seema Sahay; Ramesh A Bhosale; Sten H Vermund; Sanjay M Mehendale
Journal:  J Clin Virol       Date:  2016-10-28       Impact factor: 3.168

2.  HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer.

Authors:  Gui Liu; Monisha Sharma; Nicholas Tan; Ruanne V Barnabas
Journal:  AIDS       Date:  2018-03-27       Impact factor: 4.177

3.  Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda.

Authors:  Ronald H Gray; David Serwadda; Xiangrong Kong; Frederick Makumbi; Godfrey Kigozi; Patti E Gravitt; Stephen Watya; Fred Nalugoda; Victor Ssempijja; Aaron A R Tobian; Noah Kiwanuka; Lawrence H Moulton; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Boaz Iga; Oliver Laeyendecker; Amy E Oliver; Maria J Wawer
Journal:  J Infect Dis       Date:  2010-05-15       Impact factor: 5.226

4.  Circumcision of HIV-infected men: effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda.

Authors:  David Serwadda; Maria J Wawer; Frederick Makumbi; Xiangrong Kong; Godfrey Kigozi; Patti Gravitt; Stephen Watya; Fred Nalugoda; Victor Ssempijja; Aaron A R Tobian; Noah Kiwanuka; Lawrence H Moulton; Nelson K Sewankambo; Steven J Reynolds; Thomas C Quinn; Amy E Oliver; Boaz Iga; Oliver Laeyendecker; Ronald H Gray
Journal:  J Infect Dis       Date:  2010-05-15       Impact factor: 5.226

5.  MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa.

Authors:  Giulia Calenda; Guillermo Villegas; Patrick Barnable; Claudia Litterst; Keith Levendosky; Agegnehu Gettie; Michael L Cooney; James Blanchard; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

6.  Genotype-specific clearance of genital human papillomavirus (HPV) infections among mothers in the Finnish family HPV study.

Authors:  Karolina Louvanto; Kari J Syrjänen; Marjut A M Rintala; Seija E Grénman; Stina M Syrjänen
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

Review 7.  Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy.

Authors:  Patti E Gravitt; Jerome L Belinson; Jorge Salmeron; Keerti V Shah
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

8.  Association of oncogenic and nononcogenic human papillomavirus with HIV incidence.

Authors:  Bertran Auvert; Pascale Lissouba; Ewalde Cutler; Kevin Zarca; Adrian Puren; Dirk Taljaard
Journal:  J Acquir Immune Defic Syndr       Date:  2010-01       Impact factor: 3.731

9.  Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda.

Authors:  Cecily Banura; Sven Sandin; Leen-Jan van Doorn; Wim Quint; Bernhard Kleter; Fred Wabwire-Mangen; Edward K Mbidde; Elisabete Weiderpass
Journal:  Infect Agent Cancer       Date:  2010-04-09       Impact factor: 2.965

10.  Sexual behaviour and less frequent bathing are associated with higher human papillomavirus incidence in a cohort study of uncircumcised Kenyan men.

Authors:  Danielle M Backes; Peter J F Snijders; Michael G Hudgens; Robert C Bailey; Martijn Bogaarts; Kawango Agot; Walter Agingu; Stephen Moses; Chris J L M Meijer; Jennifer S Smith
Journal:  Sex Transm Infect       Date:  2012-09-01       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.